Reuters: Carlyle lines up financing for J&J diagnostics unit

Carlyle Group (CG) is preparing $3.7B in financing that will back its purchase of Johnson & Johnson's (JNJ) ortho clinical diagnostics unit in a deal expected to be signed by the end of this week, Reuters reports.

Including equity and $3.3B in funded debt, sources peg the offer price in the $4.1B-$4.5B range.

Reports last month said Carlyle was nearing a ~$4B deal for the unit; the P-E firm's exclusivity period on the deal is said to end Jan. 17.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs